Last reviewed · How we verify
platelet enriched plasma
At a glance
| Generic name | platelet enriched plasma |
|---|---|
| Sponsor | Mansoura University |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Regenerative Treatment of Female Genital Atrophy (PHASE1, PHASE2)
- Age-related Macular Degeneration of Atrophic Type Treated With Umbilical Cord Blood Enriched With Platelet Plasma. (NA)
- AGA Biocellular Stem/Stromal Hair Regenerative Study (PHASE1, PHASE2)
- Biofiller and Gingival Phenotype Thickening (NA)
- Efficacy of PRGF Supplementation After TMJ Arthrocentesis in Patients With TMJ Osteoarthritis (PHASE4)
- Evalution of the Effects of PRP and LLLT on Postoperative Complications and Wound Healing After Impacted Third Molar (NA)
- Comparing Injection Treatments for Tennis Elbow (NA)
- Stromal Vascular Fraction Enriched PRP in Treatment of Post-acne Scars (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- platelet enriched plasma CI brief — competitive landscape report
- platelet enriched plasma updates RSS · CI watch RSS
- Mansoura University portfolio CI